- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, December 15, 2023
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A study entitled, “Treatment Modification After Initiating Second-Line Medication for Type 2 Diabetes,” to be published in the December 2023 issue of The American Journal of Managed Care® (AJMC®), was referenced in articles from US News & World Report, Medpage Today, Medical News Today, Healio, HealthDay, and Medical Economics®. The study found that approximately 40% of patients with type 2 diabetes discontinued their second-line therapies within a year.
An article from Medriva referenced an article published on AJMC.com, the website of AJMC. The article, “Health Insurance Markets Remain Highly Concentrated in the Majority of US,” covered a report from the American Medical Association that found the market for health insurance, both commercial and Medicare Advantage, became more concentrated from 2014 to 2022.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
